[Clinical experimentation of a new antibiotic-azo dye combination (N4,N4-terephthalal-bis-[D-4-amino-3-isooxazolidone] + 2,6-diamino-3-phenylazo-pyridine hydrochloride) in urinary tract infections].
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use; D001391:Azo Compounds / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D000892:Anti-Infective Agents, Urinary; D001391:Azo Compounds
Sperimentazione clinica di una nuova associazione antibiotico-azocolorante (N4,N4-Tereftalal-bis-(D-4-amino-3-isossazolidone) + 2,6-diamino-3-3-fenilazo-piridina cloridrato) nelle infezioni delle vie urinarie.